Login / Signup

Third-line therapy for overactive bladder in the elderly: Nuances and considerations.

Jacqueline ZilliouxEmily A SlopnickSandip P Vasavada
Published in: Neurourology and urodynamics (2022)
Advanced age and frailty should not preclude third-line therapy for refractory OAB, as available data support their efficacy and safety in these populations. Ultimately, treatment choices should be individualized and involve shared decision-making.
Keyphrases
  • community dwelling
  • electronic health record
  • middle aged
  • big data
  • machine learning
  • combination therapy